scholarly article | Q13442814 |
P819 | ADS bibcode | 2013PLoSO...864836B |
P356 | DOI | 10.1371/JOURNAL.PONE.0064836 |
P932 | PMC publication ID | 3665539 |
P698 | PubMed publication ID | 23724100 |
P5875 | ResearchGate publication ID | 236978653 |
P50 | author | Mihoko Kikuchi | Q96254031 |
Nguyen Tien Huy | Q30511999 | ||
Kenji Hirayama | Q30512005 | ||
P2093 | author name string | Mohammed Nasir Shuaibu | |
Masachika Senba | |||
Katsuyuki Yui | |||
Tetsuo Yanagi | |||
Kiri Honma | |||
Lam Quoc Bao | |||
P2860 | cites work | Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study | Q21034132 |
Acquired immunity to malaria | Q24651173 | ||
Invariant NKT cells producing IL-4 or IL-10, but not IFN-gamma, inhibit the Th1 response in experimental autoimmune encephalomyelitis, whereas none of these cells inhibits the Th17 response | Q84102344 | ||
Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen | Q24673510 | ||
The regulation of CD5 expression in murine T cells | Q24799307 | ||
Regulatory T cells exert checks and balances on self tolerance and autoimmunity | Q28267935 | ||
The regulation of IL-10 production by immune cells | Q29615479 | ||
A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis | Q29619339 | ||
The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. | Q30445936 | ||
IL-10 from CD4CD25Foxp3CD127 adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection | Q33327498 | ||
Distinct clinical and immunologic profiles in severe malarial anemia and cerebral malaria in Zambia | Q33393958 | ||
Platelet factor 4 regulation of monocyte KLF4 in experimental cerebral malaria | Q33573493 | ||
Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy | Q33619092 | ||
Interleukin-10 mediated autoregulation of murine B-1 B-cells and its role in Borrelia hermsii infection | Q33631177 | ||
Cloned lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malaria | Q33760891 | ||
CD4+ natural regulatory T cells prevent experimental cerebral malaria via CTLA-4 when expanded in vivo | Q33775493 | ||
Identification of two cerebral malaria resistance loci using an inbred wild-derived mouse strain | Q34098000 | ||
The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). | Q34148661 | ||
B cells regulate autoimmunity by provision of IL-10. | Q34150590 | ||
Prevention of arthritis by interleukin 10-producing B cells | Q34178104 | ||
Memory B cells are a more reliable archive for historical antimalarial responses than plasma antibodies in no-longer exposed children | Q34261333 | ||
Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor | Q34292144 | ||
Induction of IL-10-producing CD1dhighCD5+ regulatory B cells following Babesia microti-infection | Q34447223 | ||
Immunological processes in malaria pathogenesis. | Q34447833 | ||
Presence of Foxp3-expressing CD19(+)CD5(+) B Cells in Human Peripheral Blood Mononuclear Cells: Human CD19(+)CD5(+)Foxp3(+) Regulatory B Cell (Breg). | Q34521067 | ||
Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis | Q34574447 | ||
Prolonged survival of a murine model of cerebral malaria by kynurenine pathway inhibition | Q34650814 | ||
A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses | Q34778834 | ||
Plasmodium berghei ANKA infection increases Foxp3, IL-10 and IL-2 in CXCL-10 deficient C57BL/6 mice | Q34809399 | ||
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression | Q34831296 | ||
ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors. | Q34978026 | ||
Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response | Q35087990 | ||
Helminth-modified pulmonary immune response protects mice from allergen-induced airway hyperresponsiveness. | Q51827445 | ||
Immunophenotypic and functional characteristics of haemopoietic cells from human cord blood | Q71767865 | ||
Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation | Q77704355 | ||
B-cell-derived interleukin-10 in autoimmune disease: regulating the regulators | Q81329072 | ||
Immune effector mechanisms in malaria | Q82383609 | ||
The natural killer complex regulates severe malarial pathogenesis and influences acquired immune responses to Plasmodium berghei ANKA. | Q42250672 | ||
Recombinant human IFN-alpha inhibits cerebral malaria and reduces parasite burden in mice | Q45027585 | ||
Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria. | Q45997398 | ||
Post-transcriptional regulation of adapter molecules by IL-10 inhibits TLR-mediated activation of antigen-presenting cells | Q46249994 | ||
Severe malaria in Gambian children is not due to lack of previous exposure to malaria | Q46327398 | ||
Prevalence and case-control study of cerebral malaria in Limbe of the South-West Cameroon. | Q46989125 | ||
Interleukin-10 modulates susceptibility in experimental cerebral malaria. | Q47823424 | ||
Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment | Q47835825 | ||
Interleukin 10-mediated immunosuppression by a variant CD4 T cell epitope of Plasmodium falciparum | Q47849915 | ||
Involvement of IFN-gamma receptor-medicated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection | Q47868505 | ||
CD4(+) T cell response in early erythrocytic stage malaria: Plasmodium berghei infection in BALB/c and C57BL/6 mice | Q47899546 | ||
Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria | Q47910654 | ||
Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis | Q47923237 | ||
Regulation of murine cerebral malaria pathogenesis by CD1d-restricted NKT cells and the natural killer complex | Q47925580 | ||
Filaria-induced IL-10 suppresses murine cerebral malaria | Q47940113 | ||
Coincident parasite and CD8 T cell sequestration is required for development of experimental cerebral malaria | Q47953889 | ||
Granzyme B expression by CD8+ T cells is required for the development of experimental cerebral malaria | Q47978572 | ||
Cutting edge: the acquisition of TLR tolerance during malaria infection impacts T cell activation | Q48008155 | ||
Behavioural and histopathological alterations in mice with cerebral malaria | Q48027109 | ||
Foxp3-positive macrophages display immunosuppressive properties and promote tumor growth | Q35102281 | ||
Interleukin-10 therapy--review of a new approach | Q35139563 | ||
The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology | Q35180114 | ||
Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria | Q35216393 | ||
B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice | Q35345025 | ||
Critical role of the neutrophil-associated high-affinity receptor for IgE in the pathogenesis of experimental cerebral malaria | Q35441422 | ||
IL-27 promotes IL-10 production by effector Th1 CD4+ T cells: a critical mechanism for protection from severe immunopathology during malaria infection | Q35737807 | ||
CD19 expression in B cells is important for suppression of contact hypersensitivity | Q35916042 | ||
B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells | Q35946128 | ||
IFN-γ-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain | Q36086895 | ||
Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children | Q36345204 | ||
Immunopathogenesis of cerebral malaria. | Q36469898 | ||
A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. | Q36595999 | ||
C5 deficiency and C5a or C5aR blockade protects against cerebral malaria | Q36640015 | ||
The 'short' history of regulatory B cells | Q37090662 | ||
IL-10: the master regulator of immunity to infection | Q37143028 | ||
Not always the bad guys: B cells as regulators of autoimmune pathology | Q37147738 | ||
Immunity to malaria: more questions than answers | Q37194482 | ||
Regulatory B cells as inhibitors of immune responses and inflammation | Q37256986 | ||
Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area | Q37269963 | ||
Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis | Q37453905 | ||
Patent filarial infection modulates malaria-specific type 1 cytokine responses in an IL-10-dependent manner in a filaria/malaria-coinfected population | Q37462905 | ||
Effector and regulatory B cells: modulators of CD4+ T cell immunity | Q37708012 | ||
Interferon-γ--central mediator of protective immune responses against the pre-erythrocytic and blood stage of malaria | Q37770828 | ||
Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria | Q38994034 | ||
Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria | Q39029074 | ||
Rate of red blood cell destruction varies in different strains of mice infected with Plasmodium berghei-ANKA after chronic exposure | Q39062944 | ||
Disruption of JNK2 decreases the cytokine response to Plasmodium falciparum glycosylphosphatidylinositol in vitro and confers protection in a cerebral malaria model | Q39192335 | ||
Indicators of life-threatening malaria in African children | Q39217563 | ||
Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum | Q39362892 | ||
Peripheral blood dendritic cells in children with acute Plasmodium falciparum malaria. | Q39584005 | ||
Cytokine and chemokine responses in a cerebral malaria-susceptible or -resistant strain of mice to Plasmodium berghei ANKA infection: early chemokine expression in the brain | Q40655162 | ||
Novel highly sensitive IL-10-beta-lactamase reporter mouse reveals cells of the innate immune system as a substantial source of IL-10 in vivo | Q41427050 | ||
Accumulation of Plasmodium berghei-infected red blood cells in the brain is crucial for the development of cerebral malaria in mice | Q41811005 | ||
Secreted antibody is required for immunity to Plasmodium berghei | Q41833764 | ||
Systemic endothelial activation occurs in both mild and severe malaria. Correlating dermal microvascular endothelial cell phenotype and soluble cell adhesion molecules with disease severity | Q42116149 | ||
IL-10 therapy in Crohn's disease: at the crossroads. Treatment of Crohn's disease with the anti-inflammatory cytokine interleukin 10. | Q42150160 | ||
Severe malarial anemia of low parasite burden in rodent models results from accelerated clearance of uninfected erythrocytes | Q42155978 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cerebral malaria | Q2822915 |
malaria | Q12156 | ||
P304 | page(s) | e64836 | |
P577 | publication date | 2013-01-01 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | CD19(+) B cells confer protection against experimental cerebral malaria in semi-immune rodent model | |
P478 | volume | 8 |
Q90221000 | Erythrocyte binding ligand region VI specific IgA confers tissue protection in malaria infection |
Q63363286 | Infection-Induced Resistance to Experimental Cerebral Malaria Is Dependent Upon Secreted Antibody-Mediated Inhibition of Pathogenic CD8 T Cell Responses |
Q40956254 | Parasite-Specific CD4+ IFN-γ+ IL-10+ T Cells Distribute within Both Lymphoid and Nonlymphoid Compartments and Are Controlled Systemically by Interleukin-27 and ICOS during Blood-Stage Malaria Infection |
Q54257360 | Potential Role for Regulatory B Cells as a Major Source of Interleukin-10 in Spleen from Plasmodium chabaudi-Infected Mice. |
Q38891874 | Splenic CD11c+ cells derived from semi-immune mice protect naïve mice against experimental cerebral malaria |
Q59341040 | TACI Contributes to Host Resistance by Controlling T Follicular Helper Cell Response and Germinal Center Formation |
Q38891868 | Tacrolimus prevents murine cerebral malaria |
Q40273988 | What do we know about the role of regulatory B cells (Breg) during the course of infection of two major parasitic diseases, malaria and leishmaniasis? |
Search more.